Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px
Document › Details

Bit Bio Ltd.. (10/15/19). "Press Release: Elpis Becomes Bit Bio. We Are Excited to Announce Our Transition to the Cell Coding Company!".

Organisations Organisation Bit Bio Ltd.
  Organisation 2 University of Cambridge
Products Product cell research product
  Product 2 cell therapy
Person Person Kotter, Mark (Elpis BioMed 2017– CEO + Founder)
     


Who we are :

Founded in 2016 by Dr Mark Kotter, Bit Bio (formerly Elpis Biomed) is an award-winning spinout from the University of Cambridge. By applying an engineering approach to synthetic and stem cell biology, Mark and his team have developed proprietary technologies for the efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy.

‘Bit Bio’ represents the two fields — coding and biology — that determine the Identity of every human cell. Ultimately, bits are the building blocks of code, just as cells are the building blocks of life. This is reflective of what Bit Bio does: precise reprogramming of human stem cells.

Our mission and focus are to enable a new generation of therapies through democratising access to consistent and functional human cells. This will improve research and drug discovery, lower the cost and extend the application of cell therapies.

   
Record changed: 2019-12-11

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Bit Bio Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px




» top